Results 361 to 370 of about 465,225 (381)
Some of the next articles are maybe not open access.
Nicotine and Nicotinic Receptors; Relevance to Parkinson’s Disease
NeuroToxicology, 2002The development of nicotinic agonists for therapy in neurodegenerative disorders such as Parkinson's disease is an area currently receiving considerable attention. The rationale for such work stems from findings that reveal a loss of nicotinic receptors in Parkinson's disease brains.
Maryka Quik, Jennifer M. Kulak
openaire +2 more sources
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.
British Journal of Addiction, 1991T. Heatherton +3 more
semanticscholar +1 more source
Treating Tobacco Addiction — Nicotine or No Nicotine?
New England Journal of Medicine, 1997Nicotine has been the mainstay of pharmacotherapy for tobacco addiction, but other medications, such as the antidepressant drugs bupropion and nortriptyline, are also effective.
openaire +2 more sources
Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia
Neurotoxicity Research, 2007Schizophrenia is a complex neuropsychiatric disorder with devastating consequences. It is characterized by thought fragmentation, hallucination and delusion, collectively referred to as positive symptoms. In addition, mood changes or affective disorders, referred to as negative symptoms, as well as cognitive impairments can be manifested in these ...
openaire +3 more sources
Nicotine replacement therapy for smoking cessation.
Cochrane Database of Systematic Reviews, 2008L. Stead +4 more
semanticscholar +1 more source
Metabolism and Disposition Kinetics of Nicotine
Pharmacological Reviews, 2005J. Hukkanen, Pleyton Jacob, N. Benowitz
semanticscholar +1 more source